Cargando…

Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience

Background: Whether nebulized polymyxin B should be used as an adjunctive therapy or substitution strategy to intravenous polymyxin B for the treatment of ventilator-associated pneumonia (VAP) remains controversial. This study’s aim is to evaluate the efficacy and safety of different administration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Rupeng, Fu, Yuanyuan, Gan, Yujing, Wu, Danying, Zhou, Suming, Huang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502420/ https://www.ncbi.nlm.nih.gov/pubmed/37719858 http://dx.doi.org/10.3389/fphar.2023.1222044

Ejemplares similares

Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients
por: Liang, Danhong, et al.
Publicado: (2023)

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study
por: Wu, Zhenping, et al.
Publicado: (2023)

The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation
por: Zou, Dongna, et al.
Publicado: (2021)

2293. Revival of Polymyxins: A Single-Center Historical Cohort of Critically Ill Patients in Brazil
por: Maria Dantas de Maio Carrilho, Claudia, et al.
Publicado: (2019)

Risk Factors of Ventilator-Associated Pneumonia in Critically III Patients
por: Wu, Diling, et al.
Publicado: (2019)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
por: Zeng, Huihui, et al.
Publicado: (2021)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
por: Yu, Zhenwei, et al.
Publicado: (2022)

Association of thiamine administration and prognosis in critically ill patients with heart failure
por: Yang, Rui, et al.
Publicado: (2023)

Comparison of Polymyxin E and Polymyxin B as an Additive to Pulmonary Surfactant in Escherichia coli Pneumonia of Ventilated Neonatal Rabbits
por: Stichtenoth, Guido, et al.
Publicado: (2017)

Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae
por: Diep, John K., et al.
Publicado: (2018)

The Susceptibility of MDR-K. Pneumoniae To Polymyxin B Plus Its Nebulised Form Versus Polymyxin B Alone in Critically Ill South Asian Patients
por: Hasan, Md. Jahidul, et al.
Publicado: (2021)

Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study
por: Chen, Bailiang, et al.
Publicado: (2022)

Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
por: Tran, Thien B., et al.
Publicado: (2018)

Effectiveness, nephrotoxicity, and therapeutic drug monitoring of polymyxin B in nosocomial pneumonia among critically ill patients
por: Ye, Qinghua, et al.
Publicado: (2022)

Population pharmacokinetic analysis, renal safety, and dosing optimization of polymyxin B in lung transplant recipients with pneumonia: A prospective study
por: Cai, Xiao-Jun, et al.
Publicado: (2022)

Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study
por: Fang, Jie, et al.
Publicado: (2021)

Polymyxin for treatment of ventilator-associated pneumonia in a setting of high carbapenem resistance
por: Bento Talizin, Thalita, et al.
Publicado: (2020)

Case Report: Respiratory paralysis associated with polymyxin B therapy
por: Ning, Yachan, et al.
Publicado: (2022)

Polymyxin B in Patients With Renal Impairment: Is It Necessary to Adjust Dose?
por: Nie, Ruifang, et al.
Publicado: (2022)

In silico genome-scale metabolic modeling and in vitro static time-kill studies of exogenous metabolites alone and with polymyxin B against Klebsiella pneumoniae
por: Chung, Wan Yean, et al.
Publicado: (2022)

Visualizing the Potential Impairment of Polymyxin B to Central Nervous System Through MR Susceptibility-Weighted Imaging
por: Zhang, Ni, et al.
Publicado: (2021)

Drug Prevention and Control of Ventilator-Associated Pneumonia
por: Xie, Xinming, et al.
Publicado: (2019)

Skin Hyperpigmentation in Coronavirus Disease 2019 Patients: Is Polymyxin B the Culprit?
por: Lu, Cuicui, et al.
Publicado: (2020)

Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients
por: Li, Ying, et al.
Publicado: (2021)

PKPD Modeling of the Inoculum Effect of Acinetobacter baumannii on Polymyxin B in vivo
por: Chauzy, Alexia, et al.
Publicado: (2022)

Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control study
por: Liu, Jiao, et al.
Publicado: (2022)

Prevention and treatment of ventilator-associated pneumonia in COVID-19
por: Deng, Jiayi, et al.
Publicado: (2022)

Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections
por: Wang, Peile, et al.
Publicado: (2021)

Ventilator-associated pneumonia in critically ill patients with COVID-19
por: Maes, Mailis, et al.
Publicado: (2021)

Appropriate Antibiotic Administration in Critically Ill Patients with Pneumonia
por: Khan, R. A., et al.
Publicado: (2015)

Parenteral polymyxins: Assessing efficacy and safety in critically ill patients with renal dysfunction
por: Sekhri, Kavita, et al.
Publicado: (2013)

The Determination of Polymyxin B in Critically Ill Patients by the HPLC-MS/MS Method
por: Wang, Yirong, et al.
Publicado: (2023)

Effects of Gastric Acid Secretion Inhibitors for Ventilator-Associated Pneumonia
por: Li, Fang, et al.
Publicado: (2022)

The Use of Antibiotics for Ventilator-Associated Pneumonia in the MIMIC-IV Database
por: Yang, Rui, et al.
Publicado: (2022)

Research Trends and Collaboration Patterns on Polymyxin Resistance: A Bibliometric Analysis (2010–2019)
por: Quincho-Lopez, Alvaro, et al.
Publicado: (2021)

Effects of combination therapy with Shenfu Injection in critically ill patients with septic shock receiving mechanical ventilation: A multicentric, real-world study
por: Li, Xiaoqian, et al.
Publicado: (2022)

Probiotics for Preventing Ventilator-Associated Pneumonia in Mechanically Ventilated Patients: A Meta-Analysis with Trial Sequential Analysis
por: Weng, Hong, et al.
Publicado: (2017)

Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021)

Viral-Reactivated Pneumonia during Mechanical Ventilation: Is There Need for Antiviral Treatment?
por: López-Giraldo, Alejandra, et al.
Publicado: (2011)

Adverse Drug Reactions Caused by Antimicrobials Treatment for Ventilator-Associated Pneumonia
por: Shen, Shan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tu50afrcsqcfq949lkdenaodui